Erscheint 4 Ausgaben pro Jahr
ISSN Druckformat: 0731-8898
ISSN Online: 2162-6537
Indexed in
Zoledronic Acid Aggravates Kidney Damage During Ischemia Reperfusion Injury in Rat
ABSTRAKT
Introduction: Zoledronic acid (ZA), a bisphosphonate, increases the levels of cytokines, such as interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF-α), and reactive oxygen species (ROS) in subjects without cancer. Increased production of ROS, TNF-α, and IL-6 during ischemia and reperfusion (I/R) injury stimulates apoptosis that leads to renal injury. We aimed to investigate whether ZA treatment has a protective effect on renal tissues during I/R. Materials and Methods: Twenty-four Sprague-Dawley rats were used in this study, and they were subdivided randomly into three groups, each containing eight rats. Infrarenal abdominal aortic cross ligation was performed on the I/R group. After 2 h of ischemia, 2 h of reperfusion was applied. A single dose of 100 µg/kg ZA was administered intraperitoneally to the ZA group. I/R was performed after 48 h. Results: Whereas TNF-α, IL-6, and nitric oxide (NO) levels of the I/R group were higher than those of the control group, TNF-α, IL-6, and NO levels of the ZA group were higher than those of the I/R group [TNF-α (p=0.038), IL-6 (p=0.012), NO (p=0.002), and caspase-3 (p=0.037)] and the control group [TNF-α (p<0.001), IL-6 (p<0.001), NO (p<0.001), and caspase-3 (p<0.001)]. Whereas the carbonic anhydrase II (CA-II) level of the ZA group was lower than that of the control group (p=0.040), the CA-II level of the I/R group was higher than that of the control group (p=0.020). Conclusion: ZA may aggravate renal injury during I/R by increasing cytokine production and apoptosis. It may also increase renal injury and metabolic acidosis during I/R by suppressing CA-II enzyme activities.
-
Wu Sheng-Nan, Chen Hui-Zhen, Chou Yu-Hung, Huang Yan-Ming, Lo Yi-Ching, Inhibitory actions by ibandronate sodium, a nitrogen-containing bisphosphonate, on calcium-activated potassium channels in Madin–Darby canine kidney cells, Toxicology Reports, 2, 2015. Crossref
-
Carbonare Luca Dalle, Matte’ Alessandro, Valenti Maria Teresa, Siciliano Angela, Mori Antonio, Schweiger Vittorio, Zampieri Gino, Perbellini Luigi, De Franceschi Lucia, Hypoxia-reperfusion affects osteogenic lineage and promotes sickle cell bone disease, Blood, 126, 20, 2015. Crossref
-
Pócs Levente, Janovszky Ágnes, Ocsovszki Imre, Kaszaki József, Piffkó József, Szabó Andrea, Microcirculatory consequences of limb ischemia/reperfusion in ovariectomized rats treated with zoledronic acid, Journal of Orthopaedic Surgery and Research, 14, 1, 2019. Crossref
-
Qu Xingzhou, Sun Zhaoqi, Wang Yang, Ong Hui Shan, Zoledronic acid promotes osteoclasts ferroptosis by inhibiting FBXO9-mediated p53 ubiquitination and degradation, PeerJ, 9, 2021. Crossref
-
Bakr Alaa F., Shao Ping, Farag Mohamed A., Recent advances in glycyrrhizin metabolism, health benefits, clinical effects and drug delivery systems for efficacy improvement; a comprehensive review, Phytomedicine, 99, 2022. Crossref